Outcome of the routine assessment of patients with mental retardation in a genetics clinic

American Journal of Medical Genetics

Volumn 90, Issue 1, 2000, Pages 60-68

  Hunter, Alasdair G W ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

Clinical morphology; Genetic assessment; Laboratory investigations; Mental retardation; Minor anomalies

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; FLUORESCENCE IN SITU HYBRIDIZATION; FRAGILE X SYNDROME; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICAL GENETICS; MENTAL RETARDATION MALFORMATION SYNDROME; PATIENT REFERRAL; PRIORITY JOURNAL; X CHROMOSOME LINKED DISORDER;

CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MENTAL RETARDATION;

EID: 0033986825     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(20000103)90:1<60::AID-AJMG11>3.0.CO;2-P     Document Type: Article

References (14)

1. Battaglia A, Bianchini E, Carey JC. 1999. Diagnostic yield of the comprehensive assessment of developmental delay/mental retardation in an institute of child neurophychiatry. Am J Med Genet 82:60-66.
2. Butler MG, Allen GA, Haynes JL, Singh DN, Watson MS, Breg WR. 1991. Anthropometric comparison of mentally retarded males with and without fragile X. Am J Med Genet 38:260-268.
3. Chudley AE, Gutierrez E, Jocelyn LJ, Chodirker BN. 1998. Outcomes of genetic evaluation in children with pervasive developmental disorder. Develop Behav Pediatr 19:321-325.
4. Curry CJ, Sandhu A, Frutos L, Wells R. 1996. Diagnostic yield of genetic evaluations in developmental delay/mental retardation. Clin Res 44: 130A.
5. Curry CJ, Stevenson RE, Aughton D, Byrne J, Carey JC, Cassidy S, Cunniff C, Graham JM Jr, Jones MC, Kaback MM, Moeschler J, Schaefer GB, Schwartz S, Tarleton J, Opitz J. 1997. Evaluation of mental retardation: recommendations of a Consensus Conference. Am J Med Genet 72:468-477.
6. Giangreco CA, Steel EMW, Aston CE, Cummins JH, Wenger SL. 1996. A simplified 6-item check list for screening for fragile X syndrome in the pediatric population. J Pediatr 129:611-614.
7. Hećimović S, Bariši I, Pavelić K. 1998. DNA analysis of the fragile-X syndrome in an at risk pediatric population in Croatia: simple clinical preselection criteria can considerably improve the cost-effectiveness of fragile-X screening studies. Hum Hered 48:256-265.
8. Hunter AGW, Evans JA, Thompson DR, Ramsay S. 1980. A study of institutionalized mentally retarded patients in Manitoba. I. Classification and preventability. Dev Med Child Neurol 22:145-162.
9. Moser HW, Ramey CT, Leonard CO. 1990. Mental retardation. In Emery AEH, Rimoin DL, editors. Principles and practice of medical genetics. 2nd ed. New York: Churchill Livingston. p 495-511.
10. Opitz JM, Kaveggia EG, Laxova R, Pallister PD. 1982. The diagnosis and presentation of severe mental retardation. In: Gerald PS, Nemat H, editors. Proceedings of the First International Conference on Preventable Aspects of Genetic Morbidity, vol. II. Cairo. p 117-138.
11. Root S, Viskochil D, Leonard CO, Carey JC. 1996. Genetic evaluation of children with developmental delay. Proc Greenwood Genet Ctr 15: 159-160.
12. Saul RA, Stevenson RE, Schroer RJ. 1996. Congenital anomalies in individuals with mental retardation. Proc Geenwood Genet Ctr 15:160.
13. Schroer RJ, Phelan MC, Michaelis RC, Crawford EC, Skinner SA, Cuccaro M, Simensen RJ, Bishop J, Skinner C, Fender D, Stevenson RE. 1998. Autism and maternally derived aberrations of chromosome 15q. Am J Med Genet 76:327-326.
14. Stevenson RE, Schroer RJ. 1996. Mental retardation in South Carolina 1. Characteristics of the study population. Proc Greenwood Genet Ctr 15:26-31.